# Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus

> **NCT00315614** · PHASE2 · TERMINATED · sponsor: **University of Miami** · enrollment: 3 (actual)

## Conditions studied

- Type 1 Diabetes Mellitus

## Interventions

- **BIOLOGICAL:** Islet Transplantation and Bone Marrow

## Key facts

- **NCT ID:** NCT00315614
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2000-12
- **Primary completion:** 2010-12
- **Final completion:** 2010-12
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.
- **Last updated:** 2017-04-04

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00315614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00315614, "Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00315614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*